. 2022 Jul 26;22:237. doi: 10.1186/s12871-022-01779-2

Table 3.

The cumulative dose of remimazolam and remifentanil according to the presentation of intraoperative hypotension or bradycardia

Cumulative dose	Patients without hypotension and bradycardia (n = 29)	Patient with hypotension and without bradycardia (n = 4)	Patient with hypotension and bradycardia (n = 4)	P-value
Remimazolam (mg)	72.0 (60.0–89.5)	67.5 (45.5–127.0)	77.5 (53.5–111.3)	0.257
Remifentanil (μg)	213.0 (173.5–278.0)	224.5 (182.0–296.3)	157.0 (117.0–233.0)	0.736

Cumulative dose

Patients without hypotension and bradycardia
(n = 29)

Patient with hypotension and without bradycardia
(n = 4)

Patient with hypotension and bradycardia
(n = 4)

P-value

Remimazolam (mg)

72.0

(60.0–89.5)

67.5

(45.5–127.0)

77.5

(53.5–111.3)

0.257

Remifentanil (μg)

213.0

(173.5–278.0)

224.5

(182.0–296.3)

157.0

(117.0–233.0)

0.736

Data are expressed as median (IQR)